<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Non-Hodgkin Lymphoma

Research    Blood Cancer    Non-Hodgkin Lymphoma

Phase III clinical trial results support rituximab as new standard-of-care in pediatric Burkitt lymphoma

Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated with the addition of anti-cancer immunotherapy rituximab to standard chemotherapy. The trial represents a major international collaboration between the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the Children’s Oncology Group (COG), and was led in the United States by Thomas Gross, MD, PhD, University of Colorado Cancer Center investigator and pediatric oncologist at Children’s Hospital Colorado, and in Europe by Véronique Minard-Colin, MD and Catherine Patte, MD, both pediatric oncologists at the Gustave Roussy Department of Child and Adolescent Oncology in Paris, France. The addition of rituximab decreased treatment failures by 70 percent resulting in a 10 percent increase in the three-year survival rate seen with chemotherapy alone (LMB protocol).


Author Cancer Center | Publish Date June 03, 2020
Full Story

CU Cancer Center In the News

Healio

Movie ‘distraction therapy’ improves children’s experience of radiation

news outletHealio
Publish DateJuly 15, 2021

In the 2016 animated film “Moana,” the title character bravely battled a volcanic demon and saved her people.

Full Story
La Voz

Skin Cancer Awareness

news outletLa Voz
Publish DateJuly 07, 2021

Now that summer has officially arrived, thoughts might be turning to a new seasonal look. But, before that, it might be wise to think about another look, one that results from spending too much time in the sun. Sunburn is not just an uncomfortable condition, it could be a precursor to skin cancer, the most common and potentially fatal cancer in the United States.

Full Story
MedPage Today

Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA

news outletMedPage Today
Publish DateJune 24, 2021

FDA advisors told the agency to wait on more data before approving an investigational immunotherapy for squamous carcinoma of the anal canal (SCAC), largely due to questions over the drug's activity.

Full Story
The Denver Post

Radiation therapy as a pound of prevention? A ray of hope for pancreatic cancer patients, thanks to Wings of Hope

news outletThe Denver Post
Publish DateJune 20, 2021

Using radiation to kill malignant cells in the body is nothing new, but thanks in part to funding from Wings of Hope for Pancreatic Cancer Research, oncologists are continuing to explore newer applications for one of their more standard medical therapies.

Full Story